SEPTInvestingStart Free

DBVT SCHEDULE 13G/A: SEC filing

MPM BioImpact LLC

Filed with the SEC on · accession 0001687078-26-000024

DBVT filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 13, 2026. MPM BioImpact LLC filed an amended Schedule 13G/A reporting beneficial ownership of 15,223,295 Ordinary Shares (represented by ADSs) of DBV Technologies S.A., equal to 4.8% of the class, as of September 30, 2026. The stock moved -3.6% by the first close after the filing.

Summary of the filing

MPM BioImpact LLC filed an amended Schedule 13G/A reporting beneficial ownership of 15,223,295 Ordinary Shares (represented by ADSs) of DBV Technologies S.A., equal to 4.8% of the class, as of September 30, 2026. The filing is a passive investment disclosure under Rule 13d-1(b).

For details, click here →

Key details

Ordinary Shares beneficially owned (represented by ADSs)$15.2M
Reporting person / beneficial ownerMPM BioImpact LLC
IssuerDBV Technologies S.A.
Chief financial officer, mpm bioimpact llcChristopher Wolf

How DBVT stock reacted

Close before

$11.43

Nov 12, 2026

First close after

-3.63%

$11.02

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for DBVT, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for DBVT?

Click here

Frequently asked questions

What did DBVT file with the SEC on Nov 13, 2026?

DBVT filed a SCHEDULE 13G/A (SEC filing). MPM BioImpact LLC filed an amended Schedule 13G/A reporting beneficial ownership of 15,223,295 Ordinary Shares (represented by ADSs) of DBV Technologies S.A., equal to 4.8% of the class, as of September 30, 2026. The filing is a passive investment disclosure under Rule 13d-1(b).

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did DBVT stock react to this filing?

DBVT closed at $11.43 before the filing and $11.02 on Nov 13, 2026 (-3.63%).

Other DBVT SEC filings

Get alerts when DBVT files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
DBVT overviewDBVT analysisDBVT newsLatest SEC filings